Filewrapper

Third Circuit: False endorsement claims use modified likelihood of confusion analysis

In a recent decision, the Third Circuit vacated a district court's grant of summary judgment to the plaintiff in a § 43(a) false endorsement case, but affirmed the plaintiff's summary judgment win as to the state law right of publicity claims. The dispute revolved around the National Football League's use of John Facenda's voice in […]

Continue Reading →

Federal Circuit denies rehearing en banc in DC prescription drug price case

In a precedential order today, the Federal Circuit denied a petition for rehearing and rehearing en banc in Biotechnology Industry Organization vs. District of Columbia. On August 3, the court held that the Prescription Drug Excessive Pricing Act of 2005 enacted by the District of Columbia City Council, which prohibited a patented drug from being […]

Continue Reading →

Federal Circuit affirms preemption of D.C.’s Prescription Drug Excessive Pricing Act of 2005

In a recent decision, the Federal Circuit affirmed the District Court for the District of Columbia's judgment that the federal patent laws preempted the District of Columbia's Prescription Drug Excessive Pricing Act of 2005. More details of Biotechnology Indus. Org. v. District of Columbia after the jump. The challenged legislation at issue is the Excessive […]

Continue Reading →

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up